HHS TrialBlazer: PhRMA-BIO Comment Letter – OIG-2602-N – Clinical Trial Support RFI (Anti-Kickback Statute and Beneficiary Inducements CMP)

Below is BIO's formal response to the Department of Health and Human Services' (HHS) request for Information: Categories Used in Federal Vaccine…